Summary of Purpose
To compare two dosages of low-molecular-weight heparin with placebo in the treatment of ischemic stroke.Read More →
The following dates are available for this trial. Trial information last updated on 7 September 2000.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Randomized, double-blind, placebo-controlled trial. 2750 patients were initially screened and 312 were randomized.